Dealmaking in a pandemic: partnerships speeding COVID-19 countermeasures

COVID-19 may be putting the brakes on a broad swath of biopharma deals, but it has also triggered a host of partnerships for coronavirus countermeasures, pushing vaccine deals to their highest numbers in years. Many of these arrangements knit together actors from across the development spectrum in hopes of a quick and seamless path to market.

Government agencies and non-profits have been stepping up to provide the financial fuel to get these COVID-19 countermeasures off the ground. ...